JP2022526176A5 - - Google Patents
Info
- Publication number
- JP2022526176A5 JP2022526176A5 JP2021557760A JP2021557760A JP2022526176A5 JP 2022526176 A5 JP2022526176 A5 JP 2022526176A5 JP 2021557760 A JP2021557760 A JP 2021557760A JP 2021557760 A JP2021557760 A JP 2021557760A JP 2022526176 A5 JP2022526176 A5 JP 2022526176A5
- Authority
- JP
- Japan
- Prior art keywords
- independently selected
- pharmaceutically acceptable
- substituted
- acceptable salt
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1904374.4A GB201904374D0 (en) | 2019-03-29 | 2019-03-29 | Novel compunds and pharmaceutical composistions thereof for the treatment of inflammatory disorders |
| GB1904374.4 | 2019-03-29 | ||
| PCT/EP2020/058063 WO2020200899A1 (en) | 2019-03-29 | 2020-03-24 | Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022526176A JP2022526176A (ja) | 2022-05-23 |
| JP2022526176A5 true JP2022526176A5 (https=) | 2023-04-04 |
Family
ID=66443107
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021557760A Pending JP2022526176A (ja) | 2019-03-29 | 2020-03-24 | 炎症性障害の治療のための新規化合物及びその医薬組成物 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20220194938A1 (https=) |
| EP (1) | EP3947377A1 (https=) |
| JP (1) | JP2022526176A (https=) |
| KR (1) | KR20210143904A (https=) |
| CN (1) | CN113677679A (https=) |
| AU (1) | AU2020254882A1 (https=) |
| BR (1) | BR112021019110A2 (https=) |
| CA (1) | CA3134735A1 (https=) |
| GB (1) | GB201904374D0 (https=) |
| IL (1) | IL286685A (https=) |
| MX (1) | MX2021011575A (https=) |
| PH (1) | PH12021552376A1 (https=) |
| SG (1) | SG11202110678UA (https=) |
| WO (1) | WO2020200899A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201904375D0 (en) * | 2019-03-29 | 2019-05-15 | Galapagos Nv | Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders |
| GB201904373D0 (en) * | 2019-03-29 | 2019-05-15 | Galapagos Nv | Novel compounds and pharamaceutical compositions thereof for the treatment of inflammatory disorders |
| WO2023098857A1 (zh) * | 2021-12-03 | 2023-06-08 | 武汉人福创新药物研发中心有限公司 | Irak4抑制剂及其用途 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1657242A4 (en) * | 2003-08-15 | 2008-10-29 | Banyu Pharma Co Ltd | imidazopyridine |
| JPWO2005108399A1 (ja) * | 2004-05-10 | 2008-03-21 | 萬有製薬株式会社 | イミダゾピリジン化合物 |
| JP2018524372A (ja) * | 2015-07-15 | 2018-08-30 | アウリジーン ディスカバリー テクノロジーズ リミテッド | Ｉｒａｋ−４阻害剤としてのインダゾール及びアザインダゾール化合物 |
| SG10202011653WA (en) * | 2016-06-01 | 2020-12-30 | Bayer Pharma AG | Use of 2-substituted indazoles for the treatment and prophylaxis of autoimmune diseases |
| WO2018060174A1 (de) * | 2016-09-29 | 2018-04-05 | Bayer Pharma Aktiengesellschaft | Substituierte benzimidazole, pharmazeutische präparate diese enthaltend, sowie deren verwendung zur herstellung von arzneimitteln |
| WO2018060072A1 (de) * | 2016-09-29 | 2018-04-05 | Bayer Pharma Aktiengesellschaft | Neue substituierte benzimidazole, verfahren zu ihrer herstellung, pharmazeutische präparate die diese enthalten, sowie deren verwendung zur herstellung von arzneimitteln |
| CN110835338A (zh) * | 2018-08-17 | 2020-02-25 | 浙江海正药业股份有限公司 | 咪唑并吡啶类衍生物及其制备方法和其在医药上的用途 |
| MA54755A (fr) * | 2019-01-18 | 2021-11-24 | Biogen Ma Inc | Dérivés d'imidazo[1,2-a]pyridinyle servant d'inhibiteurs d'irak4 |
| GB201904375D0 (en) * | 2019-03-29 | 2019-05-15 | Galapagos Nv | Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders |
| GB201904373D0 (en) * | 2019-03-29 | 2019-05-15 | Galapagos Nv | Novel compounds and pharamaceutical compositions thereof for the treatment of inflammatory disorders |
-
2019
- 2019-03-29 GB GBGB1904374.4A patent/GB201904374D0/en not_active Ceased
-
2020
- 2020-03-24 EP EP20715294.3A patent/EP3947377A1/en not_active Withdrawn
- 2020-03-24 CN CN202080026691.6A patent/CN113677679A/zh active Pending
- 2020-03-24 BR BR112021019110A patent/BR112021019110A2/pt not_active Application Discontinuation
- 2020-03-24 CA CA3134735A patent/CA3134735A1/en active Pending
- 2020-03-24 AU AU2020254882A patent/AU2020254882A1/en not_active Abandoned
- 2020-03-24 MX MX2021011575A patent/MX2021011575A/es unknown
- 2020-03-24 KR KR1020217035255A patent/KR20210143904A/ko not_active Withdrawn
- 2020-03-24 US US17/599,471 patent/US20220194938A1/en not_active Abandoned
- 2020-03-24 SG SG11202110678UA patent/SG11202110678UA/en unknown
- 2020-03-24 WO PCT/EP2020/058063 patent/WO2020200899A1/en not_active Ceased
- 2020-03-24 PH PH1/2021/552376A patent/PH12021552376A1/en unknown
- 2020-03-24 JP JP2021557760A patent/JP2022526176A/ja active Pending
-
2021
- 2021-09-26 IL IL286685A patent/IL286685A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022526364A5 (https=) | ||
| JP2022526176A5 (https=) | ||
| JP4495456B2 (ja) | 新規の抗炎症性アンドロスタン誘導体 | |
| KR101064787B1 (ko) | 아민 유도체 | |
| ES2307751T3 (es) | Nuevos esteres heterociclicos centi-inflamatorios 17 alfa de derivados 17 beta de carbotioato de androstano. | |
| JP4471842B2 (ja) | アミド化合物および該化合物を用いる方法 | |
| EA020374B1 (ru) | Производные бензолсульфонамида, фармацевтические композиции на их основе и применение | |
| US20100303758A1 (en) | Novel Glucocorticoid Receptor Agonists | |
| JP2018513180A5 (https=) | ||
| WO2009069032A2 (en) | Novel glucocorticoid receptor agonists | |
| JP5897186B2 (ja) | Ｐｇｄｓ阻害剤としてのフェニルオキサジアゾール誘導体 | |
| CA2867527A1 (en) | Novel ep2 receptor agonists | |
| JP2007529499A (ja) | β２受容体アゴニストとしてのフェニルアミノエタノール誘導体 | |
| US8993568B2 (en) | Morpholinyl derivatives useful as MOGAT-2 inhibitors | |
| BRPI0619260A2 (pt) | derivados de oxadiazol com atividade de receptor ctrh2, composição farmacêutica que os compreende e uso dos referidos derivados | |
| WO2015008229A1 (en) | Autotaxin inhibitors | |
| CN111620815B (zh) | 手性氯喹、羟氯喹和其衍生物及其制备方法与用途 | |
| JP4754829B2 (ja) | 抗コリン作用を有するカルバミン酸エステル | |
| KR20100047333A (ko) | 아세트아미드 입체이성체 | |
| JP4589006B2 (ja) | ムスカリン様ｍ３受容体の拮抗薬としてのヒドロキシ置換窒素複素環の新規エステル、その調製法並びに製薬組成物としてのその使用 | |
| CN102388025A (zh) | 用作p38mapk抑制剂的嘧啶并哒嗪衍生物 | |
| EP0074861B1 (en) | Aminocyclopentane esters and their preparation and pharmaceutical formulation | |
| US20170044208A1 (en) | Selective glucocorticoid receptor ligands | |
| JPWO2006118268A1 (ja) | 慢性閉塞性肺疾患治療剤 | |
| JP2009507815A (ja) | チアゾール化合物およびｐｇｄ２アンタゴニストとしてのその使用 |